UnitedHealth Group Inc.
UNHBusiness Overview
ticker: UNH step: 01 generated: 2026-05-11 source: quick-research
UnitedHealth Group Incorporated (UNH) — Business Overview
Business Description
UnitedHealth Group is the largest U.S. health insurer and integrated health services company. It operates two complementary businesses — UnitedHealthcare (health benefits/insurance) and Optum (technology-enabled care delivery, pharmacy benefits, and analytics) — across four reportable segments. Stephen Hemsley returned as CEO in May 2025 after Andrew Witty's resignation, reasserting the integrated care model.
Revenue Model
- UnitedHealthcare (~50% of revenue): Premiums from commercial (employer-sponsored + individual), Medicare Advantage, Medicare Part D, Medicaid, and TRICARE members
- Optum Rx (~25% of revenue): Pharmacy benefits management (PBM) — manages drug benefits and runs mail-order/specialty pharmacy
- Optum Health (~15% of revenue): Care delivery — primary care, ambulatory surgery, behavioral health, home health; value-based contracts
- Optum Insight (~10% of revenue): Software, analytics, and managed services for payers, providers, governments, life sciences
Products & Services
- UnitedHealthcare:
- Employer & Individual: commercial PPO/HMO/HSA-eligible plans for ~26M members
- Medicare & Retirement: Medicare Advantage (~7.8M members), Part D, MedSupp serving ~13.8M consumers total
- Community & State: Medicaid managed care, dual SNP plans (~7M members)
- Optum Health: Physician practices (~90,000+ aligned/employed physicians), surgery centers, MedExpress urgent care, home health
- Optum Rx: Pharmacy benefit management for ~60M+ members; specialty pharmacy
- Optum Insight: Change Healthcare (acquired 2022), EHR analytics, revenue cycle management, claims processing
Customer Base & Go-to-Market
- Members: ~50M+ U.S. medical members across all UnitedHealthcare lines
- Employers: Fortune 500 + mid-market + small business via broker channels
- Government: CMS (Medicare), states (Medicaid), DoD (TRICARE)
- Payers/providers: Other insurers and health systems contract for Optum Insight services
- Patients: Direct primary-care relationships through Optum Health clinics
Competitive Position
UNH is the largest U.S. managed care company by revenue and members. Its primary moats are (1) scale advantages in Medicare Advantage and PBM, (2) vertical integration via Optum (owning physicians, surgery centers, PBM, and analytics — diverting margin internally), (3) data scale across 50M+ members, and (4) regulatory expertise/relationships. The integrated model is also UNH's largest target — DOJ criminal and civil investigations launched July 2025 into Medicare Advantage billing practices specifically focus on whether vertical integration enabled inflated diagnoses for higher reimbursement.
Competitors: Elevance (ELV), CVS/Aetna, Cigna (CI), Humana (HUM) in insurance; Express Scripts (Cigna), Caremark (CVS) in PBM.
Key Facts
- Founded: 1977 (incorporated); current scale via decades of acquisitions
- Headquarters: Minnetonka, MN
- Employees: ~440,000
- Exchange: NYSE
- Sector / Industry: Health Care / Managed Health Care
- Market Cap: ~$255B (May 2026) — down ~55% from all-time high
- CEO: Stephen Hemsley (re-appointed May 2025; previously CEO 2006-2017)
- Dividend: ~$8 annual
Financial Snapshot
ticker: UNH step: 04 generated: 2026-05-11 source: quick-research
UnitedHealth Group Incorporated (UNH) — Financial Snapshot
Income Statement Summary
| Metric | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|
| Revenue | $371.6B | $400.3B | $448.0B | +12% |
| Adjusted Operating Margin | 8.8% | 5.2% | 2.7% | -2.5pp |
| Net Income | $22.4B | $14.4B | $12.1B | -16% |
| Adjusted EPS | $25.12 | $27.66 | $26.50 | -4% |
| Medical Loss Ratio | 83.2% | 85.5% | 88.9% | +3.4pp |
Segment Revenue (FY2025 approximate)
| Segment | Revenue | YoY |
|---|---|---|
| UnitedHealthcare | ~$300B | +13% |
| Optum Rx | ~$130B | +12% |
| Optum Health | ~$110B | -2% (under pressure) |
| Optum Insight | ~$20B | +5% |
| Inter-segment eliminations | ($112B) |
Membership (FY2025)
| Segment | Members |
|---|---|
| Total US Medical | ~50M |
| Medicare Advantage | ~7.8M (+755K growth in 2025 including dual-eligible) |
| Commercial Risk + Fee | ~26M |
| Medicaid | ~7M |
| Optum Rx PBM | ~60M+ |
Cash Flow & Balance Sheet (FY2025)
| Metric | Value |
|---|---|
| Cash Flow from Operations | ~$24B (sharply down from $29.7B in 2024) |
| Capital Expenditures | ~($3.5B) |
| Free Cash Flow | ~$20B |
| Cash & Investments | ~$130B (mostly held to back insurance liabilities) |
| Total Debt | ~$80B |
| Stockholders' Equity | ~$96B |
Key Ratios (approximate, May 2026)
- P/E (forward): ~13x | EV/EBITDA: ~10x | Dividend Yield: ~2.9%
- ROE: ~13% (down from 22%+ pre-pressure) | ROIC: ~10%
- Debt/Capital: ~45%
Growth Profile
2025 was the most challenging year in UNH's modern history. Revenue grew 12% but profits fell to $12.1B (lowest since 2018), and operating margin collapsed from 5.2% → 2.7% under three pressures: (1) CMS Medicare Advantage funding cuts under V28 risk model, (2) Inflation Reduction Act drug pricing changes, and (3) elevated medical cost trend across Medicare cohorts. Management's 2026 outlook is for revenue >$439B (~2% decline) — the first revenue decline in a decade. Triggered a ~20% single-day plunge in January 2026.
Forward Estimates
- 2026E Revenue: ~$439-445B (UNH guidance: revenue decline first time in a decade)
- 2026E EPS: ~$22-24 (consensus, materially below 2024 peak of $27.66)
- 2027E EPS: ~$26-28 (consensus, with recovery assumed if Medicare reset stabilizes)
- Medical Cost Trend: Management modeling continued elevated trend
Capital Return
- Dividend
$8/share annual ($7.3B), grown each of last 15+ years - Buybacks moderated in 2025/26 to preserve capital amid investigation overhang
- Insider buying: Notable Hemsley + other executive open-market purchases following stock decline
Deeper Financial Analysis
The fundamental tier adds 9 additional research dimensions for $UNH.